Xiaorong Zhong
Overview
Explore the profile of Xiaorong Zhong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
604
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhou D, Zhao M, Zhong X, Liu N, Chen X, Li D
Food Res Int
. 2025 Mar;
207:116069.
PMID: 40086960
1,3-diacylglycerol (DAG) is a natural lipid and known as functional oil. Here, we evaluated the potential of different natural deep eutectic solvents (NADESs) in synthesis of 1,3-DAG through Candida antarctica...
2.
Wenwen , Jiang Z, Liu J, Liu D, Li Y, He Y, et al.
BMC Cancer
. 2025 Feb;
25(1):291.
PMID: 39966783
Objective: This study aimed to evaluate the predictive value of implementing machine learning models based on ultrasound radiomics and clinicopathological features in the survival analysis of triple-negative breast cancer (TNBC)...
3.
Si M, Jiao Y, Xu L, Lin R, Zhong X, Lv Q
World J Surg Oncol
. 2025 Feb;
23(1):52.
PMID: 39953494
Background And Objective: Nipple-sparing mastectomy (NSM) and skin-sparing mastectomy (SSM) are recognized for their aesthetic benefits in breast cancer patients. However, detailed evaluations with large samples of their long-term oncological...
4.
Zhang J, Shi L, Zhong X, Bai Y, Dou J, Zhang L, et al.
Sci Rep
. 2025 Feb;
15(1):4775.
PMID: 39922888
To improve the economic benefits, exogenous hormones are used to control follicular development and synchronize ovulation in the batch flow management of gilts and weaned sows. Equine chorionic gonadotropin (eCG)...
5.
Wu X, Zhang W, Lu X, Zhong X, Bu H
Sci Rep
. 2024 Oct;
14(1):24431.
PMID: 39424816
ER+/HER2- breast cancer is a common subtype of breast cancer. This study aimed to evaluate the prognostic value of ER-to-PR difference (EPD) in ER+/HER2- early breast cancer (EBC). A retrospective...
6.
Zhuang L, Zhong X, Xu L, Tian C, Yu W
Sensors (Basel)
. 2024 May;
24(10).
PMID: 38793834
Localization and perception play an important role as the basis of autonomous Unmanned Aerial Vehicle (UAV) applications, providing the internal state of movements and the external understanding of environments. Simultaneous...
7.
Chen L, Yan X, Luo T, Tian T, He P, Zhong X
Cancer Med
. 2024 May;
13(10):e7295.
PMID: 38785215
Background: This prospective real-world study aimed to assess the efficacy and safety of eribulin in the clinical practice against advanced breast cancer (ABC) in China. Patients And Methods: In this...
8.
Luo T, Zhu K, Zhong X, He P, Yan X, Tian T
Transl Breast Cancer Res
. 2024 May;
4:33.
PMID: 38751470
Background: We report a case of hormone receptor (HR) positive, human epidermal growth factor receptor-2 (HER2) negative breast cancer with multiple liver metastases who achieved good clinical benefit across cyclin-dependent...
9.
Cao S, Long X, Xiao L, Zhang P, Shen M, Chen F, et al.
Front Oncol
. 2024 Mar;
14:1356778.
PMID: 38549944
Introduction: Triple-negative breast cancer (TNBC) is characterized by its aggressive nature and absence of specific therapeutic targets, necessitating the reliance on chemotherapy as the primary treatment modality. However, the drug...
10.
Zhu K, Yang X, Tai H, Zhong X, Luo T, Zheng H
Biomark Res
. 2024 Feb;
12(1):16.
PMID: 38308374
Abnormal alterations in human epidermal growth factor receptor 2 (HER2, neu, and erbB2) are associated with the development of many tumors. It is currently a crucial treatment for multiple cancers....